[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Redeye_ Redeye Redeye posts on X about $geno, geno, $ver, topics the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::153838561/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::153838561/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XXX +23% - X Year XXXXX +41% ### Followers: XXXXXX [#](/creator/twitter::153838561/followers)  - X Week XXXXXX +0.10% - X Month XXXXXX +0.13% - X Months XXXXXX -XXXX% - X Year XXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::153838561/influencer_rank)  ### Social Influence [#](/creator/twitter::153838561/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% [stocks](/list/stocks) XXXX% [exchanges](/list/exchanges) XXXX% **Social topic influence** [$geno](/topic/$geno) #3, [geno](/topic/geno) #21, [$ver](/topic/$ver) 0.85%, [topics](/topic/topics) 0.57%, [$vit](/topic/$vit) #1, [$chef](/topic/$chef) #3, [$helio](/topic/$helio) 0.28%, [ab](/topic/ab) 0.28%, [$ptrk](/topic/$ptrk) 0.28%, [$de](/topic/$de) XXXX% **Top accounts mentioned or mentioned by** [@smarteyeab](/creator/undefined) [@longriver_hk](/creator/undefined) [@safelloab](/creator/undefined) [@taocat_agent](/creator/undefined) [@10_ch_10](/creator/undefined) [@tomasotterbeck](/creator/undefined) [@thome_fole](/creator/undefined) [@fredrikkjell](/creator/undefined) [@michaelgielkens](/creator/undefined) [@simplerinvestor](/creator/undefined) [@chad_pumpiano](/creator/undefined) [@saeschinv](/creator/undefined) **Top assets mentioned** [GenomeFi (GENO)](/topic/$geno) [Team Vitality Fan Token (VIT)](/topic/$vit) [HELIO AI (HELIO)](/topic/$helio) [Deere & Company (DE)](/topic/$de) [Biconomy (BICO)](/topic/$bico) [iMe Lab (LIME)](/topic/$lime) [Aventus (AVT)](/topic/$avt) ### Top Social Posts [#](/creator/twitter::153838561/posts) --- Top posts by engagements in the last XX hours "Redeye comments on Heliospectras proposed SEK49.5m rights issue partly secured by main shareholder Weland Stl AB (63% ownership). $HELIO" [X Link](https://x.com/Redeye_/status/1972955703410393572) [@Redeye_](/creator/x/Redeye_) 2025-09-30T09:24Z 14.5K followers, 1213 engagements "Physitrack is trading below Redeye's Base Case. We spoke with our analyst regarding the the current expectations for the following report Physitrack's strategy to convert the Nexa/Physitrack partnership into broader Wellness traction and other key topics. This is a premium article included in our paid plans from SEK 99/month. $PTRK" [X Link](https://x.com/Redeye_/status/1978012890620690727) [@Redeye_](/creator/x/Redeye_) 2025-10-14T08:19Z 14.5K followers, XXX engagements "Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE" [X Link](https://x.com/Redeye_/status/1978381140831457496) [@Redeye_](/creator/x/Redeye_) 2025-10-15T08:43Z 14.5K followers, XXX engagements "BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO" [X Link](https://x.com/Redeye_/status/1975477431659340000) [@Redeye_](/creator/x/Redeye_) 2025-10-07T08:24Z 14.5K followers, 1155 engagements "Redeye retains its SEK394 Base Case in Lime leaving notable upside potential given the recent soft share price performance. $LIME" [X Link](https://x.com/Redeye_/status/1973678475656806413) [@Redeye_](/creator/x/Redeye_) 2025-10-02T09:16Z 14.5K followers, XXX engagements "Redeye comments on a preliminary release ahead of its full report on XX October 2025 where AVTECH announced Q3 2025 net sales of SEK12.3 million representing XX% year-over-year growth despite adverse currency movements. $AVT" [X Link](https://x.com/Redeye_/status/1975082794624991490) [@Redeye_](/creator/x/Redeye_) 2025-10-06T06:16Z 14.5K followers, XXX engagements "Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO" [X Link](https://x.com/Redeye_/status/1955529686043501021) [@Redeye_](/creator/x/Redeye_) 2025-08-13T07:19Z 14.5K followers, 1129 engagements "Redeye comments on Verve's announced acquisition. $VER" [X Link](https://x.com/Redeye_/status/1968331752470097950) [@Redeye_](/creator/x/Redeye_) 2025-09-17T15:10Z 14.5K followers, 1332 engagements "Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER" [X Link](https://x.com/Redeye_/status/1956252758702432763) [@Redeye_](/creator/x/Redeye_) 2025-08-15T07:12Z 14.5K followers, 1790 engagements "Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT" [X Link](https://x.com/Redeye_/status/1978738525576024436) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:23Z 14.5K followers, XXX engagements "Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF" [X Link](https://x.com/Redeye_/status/1976552806464049309) [@Redeye_](/creator/x/Redeye_) 2025-10-10T07:38Z 14.5K followers, 1233 engagements "Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER" [X Link](https://x.com/Redeye_/status/1970009407556649224) [@Redeye_](/creator/x/Redeye_) 2025-09-22T06:16Z 14.5K followers, 1413 engagements "Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO" [X Link](https://x.com/Redeye_/status/1940346251234640071) [@Redeye_](/creator/x/Redeye_) 2025-07-02T09:46Z 14.5K followers, 1446 engagements "Redeye comments on todays news from Cheffelo where financial targets have been raised ahead of its now scheduled CMD. $CHEF" [X Link](https://x.com/Redeye_/status/1970748228053144046) [@Redeye_](/creator/x/Redeye_) 2025-09-24T07:12Z 14.5K followers, 1232 engagements "Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX" [X Link](https://x.com/Redeye_/status/1978738980804825380) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:25Z 14.5K followers, 1001 engagements "Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO" [X Link](https://x.com/Redeye_/status/1955189857602469971) [@Redeye_](/creator/x/Redeye_) 2025-08-12T08:49Z 14.5K followers, 1007 engagements "Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR" [X Link](https://x.com/Redeye_/status/1961072328944636250) [@Redeye_](/creator/x/Redeye_) 2025-08-28T14:24Z 14.5K followers, 1214 engagements "Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT" [X Link](https://x.com/Redeye_/status/1979058100423291260) [@Redeye_](/creator/x/Redeye_) 2025-10-17T05:33Z 14.5K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Redeye_ Redeye
Redeye posts on X about $geno, geno, $ver, topics the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XXXX%
Mentions: XX #
- X Week XX -XX%
- X Month XX -XX%
- X Months XXX +23%
- X Year XXXXX +41%
Followers: XXXXXX #
- X Week XXXXXX +0.10%
- X Month XXXXXX +0.13%
- X Months XXXXXX -XXXX%
- X Year XXXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence cryptocurrencies XXXX% finance XXXX% stocks XXXX% exchanges XXXX%
Social topic influence $geno #3, geno #21, $ver 0.85%, topics 0.57%, $vit #1, $chef #3, $helio 0.28%, ab 0.28%, $ptrk 0.28%, $de XXXX%
Top accounts mentioned or mentioned by @smarteyeab @longriver_hk @safelloab @taocat_agent @10_ch_10 @tomasotterbeck @thome_fole @fredrikkjell @michaelgielkens @simplerinvestor @chad_pumpiano @saeschinv
Top assets mentioned GenomeFi (GENO) Team Vitality Fan Token (VIT) HELIO AI (HELIO) Deere & Company (DE) Biconomy (BICO) iMe Lab (LIME) Aventus (AVT)
Top Social Posts #
Top posts by engagements in the last XX hours
"Redeye comments on Heliospectras proposed SEK49.5m rights issue partly secured by main shareholder Weland Stl AB (63% ownership). $HELIO"
X Link @Redeye_ 2025-09-30T09:24Z 14.5K followers, 1213 engagements
"Physitrack is trading below Redeye's Base Case. We spoke with our analyst regarding the the current expectations for the following report Physitrack's strategy to convert the Nexa/Physitrack partnership into broader Wellness traction and other key topics. This is a premium article included in our paid plans from SEK 99/month. $PTRK"
X Link @Redeye_ 2025-10-14T08:19Z 14.5K followers, XXX engagements
"Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE"
X Link @Redeye_ 2025-10-15T08:43Z 14.5K followers, XXX engagements
"BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO"
X Link @Redeye_ 2025-10-07T08:24Z 14.5K followers, 1155 engagements
"Redeye retains its SEK394 Base Case in Lime leaving notable upside potential given the recent soft share price performance. $LIME"
X Link @Redeye_ 2025-10-02T09:16Z 14.5K followers, XXX engagements
"Redeye comments on a preliminary release ahead of its full report on XX October 2025 where AVTECH announced Q3 2025 net sales of SEK12.3 million representing XX% year-over-year growth despite adverse currency movements. $AVT"
X Link @Redeye_ 2025-10-06T06:16Z 14.5K followers, XXX engagements
"Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO"
X Link @Redeye_ 2025-08-13T07:19Z 14.5K followers, 1129 engagements
"Redeye comments on Verve's announced acquisition. $VER"
X Link @Redeye_ 2025-09-17T15:10Z 14.5K followers, 1332 engagements
"Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER"
X Link @Redeye_ 2025-08-15T07:12Z 14.5K followers, 1790 engagements
"Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT"
X Link @Redeye_ 2025-10-16T08:23Z 14.5K followers, XXX engagements
"Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF"
X Link @Redeye_ 2025-10-10T07:38Z 14.5K followers, 1233 engagements
"Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER"
X Link @Redeye_ 2025-09-22T06:16Z 14.5K followers, 1413 engagements
"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link @Redeye_ 2025-07-02T09:46Z 14.5K followers, 1446 engagements
"Redeye comments on todays news from Cheffelo where financial targets have been raised ahead of its now scheduled CMD. $CHEF"
X Link @Redeye_ 2025-09-24T07:12Z 14.5K followers, 1232 engagements
"Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX"
X Link @Redeye_ 2025-10-16T08:25Z 14.5K followers, 1001 engagements
"Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO"
X Link @Redeye_ 2025-08-12T08:49Z 14.5K followers, 1007 engagements
"Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR"
X Link @Redeye_ 2025-08-28T14:24Z 14.5K followers, 1214 engagements
"Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT"
X Link @Redeye_ 2025-10-17T05:33Z 14.5K followers, XXX engagements